Suppr超能文献

相似文献

1
Comparative dissolution study on counterfeit medicines of PDE-5 inhibitors.
J Pharm Anal. 2014 Aug;4(4):250-257. doi: 10.1016/j.jpha.2014.03.002. Epub 2014 Mar 13.
2
Evaluation of impurities and dissolution profiles of illegal antimicrobial drugs encountered in Belgium.
Drug Test Anal. 2020 Jan;12(1):53-66. doi: 10.1002/dta.2690. Epub 2019 Sep 10.
3
Identification of counterfeit medicines for erectile dysfunction from an illegal supply chain.
Arh Hig Rada Toksikol. 2010 Mar;61(1):69-75. doi: 10.2478/10004-1254-61-2010-1953.
6
The identification of (-)-trans-tadalafil, tadalafil, and sildenafil in counterfeit Cialis and the optical purity of tadalafil stereoisomers.
J Pharm Biomed Anal. 2010 Feb 5;51(3):723-7. doi: 10.1016/j.jpba.2009.08.010. Epub 2009 Aug 14.
7
Chemometrics and chromatographic fingerprints to discriminate and classify counterfeit medicines containing PDE-5 inhibitors.
Talanta. 2012 Oct 15;100:123-33. doi: 10.1016/j.talanta.2012.08.029. Epub 2012 Aug 31.
8
[Are there counterfeit medicines in Croatia?].
Lijec Vjesn. 2010 Mar-Apr;132(3-4):81-6.
10
Counterfeit drugs and medical devices in developing countries.
Res Rep Trop Med. 2014 Apr 24;5:11-22. doi: 10.2147/RRTM.S39354. eCollection 2014.

本文引用的文献

1
Chromatography in the detection and characterization of illegal pharmaceutical preparations.
J Chromatogr Sci. 2013 Sep;51(8):791-806. doi: 10.1093/chromsci/bmt006. Epub 2013 Jan 31.
2
Validation of analytical methods involved in dissolution assays: acceptance limits and decision methodologies.
Anal Chim Acta. 2012 Nov 2;751:44-51. doi: 10.1016/j.aca.2012.09.017. Epub 2012 Sep 20.
4
Are counterfeit or substandard anti-infective products the cause of treatment failure in Papua New Guinea?
J Pharm Sci. 2011 Nov;100(11):5059-68. doi: 10.1002/jps.22691. Epub 2011 Jun 30.
5
The global counterfeit drug trade: patient safety and public health risks.
J Pharm Sci. 2011 Nov;100(11):4571-9. doi: 10.1002/jps.22679. Epub 2011 Jun 22.
6
Economic analysis of use of counterfeit drugs: health impairment risk of counterfeit phosphodiesterase type 5 inhibitor taken as an example.
Environ Health Prev Med. 2010 Jul;15(4):244-51. doi: 10.1007/s12199-010-0134-5. Epub 2010 Feb 9.
7
Growing threat from counterfeit medicines.
Bull World Health Organ. 2010 Apr;88(4):247-8. doi: 10.2471/BLT.10.020410.
8
Antimalarial drug quality in Africa.
J Clin Pharm Ther. 2007 Oct;32(5):429-40. doi: 10.1111/j.1365-2710.2007.00847.x.
10
The quality of sulphadoxine-pyrimethamine and amodiaquine products in the Kenyan retail sector.
J Clin Pharm Ther. 2005 Dec;30(6):559-65. doi: 10.1111/j.1365-2710.2005.00685.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验